Suppr超能文献

莪术散加升麻散治疗胃食管反流相关性慢性咳嗽的疗效和安全性:一项前瞻性、随机、双盲、安慰剂对照试验方案。

Efficacy and safety of Ojeok-san plus Saengmaek-san for gastroesophageal reflux-induced chronic cough: protocol for a pilot, randomized, double-blind, placebo-controlled trial.

机构信息

Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyung Heedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.

Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyung Heedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.

出版信息

Trials. 2020 Jan 29;21(1):118. doi: 10.1186/s13063-019-4030-z.

Abstract

BACKGROUND

Gastroesophageal reflux disease (GERD) is a major cause of chronic cough. GERD-induced chronic cough is difficult to diagnose because some patients do not complain of any gastrointestinal (GI) reflux symptoms. Although chronic cough due to GERD is highly prevalent, no effective treatment is currently available, especially for GERD-related cough without GI symptoms. Because the herbal medicines Ojeok-san and Saengmaek-san can effectively treat GERD and cough, we aim to evaluate the efficacy and safety of a combination of these components for relieving chronic cough due to GERD.

METHODS/DESIGN: This is a study protocol of a randomized, double-blind, placebo-controlled, single-center pilot trial. After a 1-week run-in period, a total of 30 patients with GERD-induced chronic cough will be randomly allocated to an intervention group (n = 15) or a placebo group (n = 15). Participants will receive 5.76 g of Ojeok-san plus Saengmaek-san or a placebo three times per day for 6 weeks. The primary outcome measures, which are the frequency and severity of cough, will be recorded using a cough diary. The secondary outcome measures will include a cough visual analogue scale, the Leicester Cough Questionnaire (Korean version), the Gastrointestinal Symptom Rating Scale, the Hull Airway Reflux (hypersensitivity) Questionnaire, the Pattern Identification for Chronic Cough Questionnaire, the Pattern Identification for Gastroesophageal Reflux Disease, and safety testing. Adverse events will also be reported.

DISCUSSION

This will be the first clinical trial to explore the use of herbal medicines for GERD-related chronic cough, including patients without GI reflux symptoms. This study will provide useful evidence regarding the efficacy and safety of Ojeok-san plus Saengmaek-san treatment. In addition, this trial will offer a scientific basis for the combination of herbal medicines. This study will also provide important data for conducting a larger-scale clinical trial on GERD-induced chronic cough.

TRIAL REGISTRATION

This trial has been registered with Clinical Research Information Service (CRIS) of South Korea (http://cris.nih.go.kr; registration number KCT0003115). Registered August 28, 2018.

摘要

背景

胃食管反流病(GERD)是慢性咳嗽的主要原因。GERD 引起的慢性咳嗽难以诊断,因为有些患者没有任何胃肠道(GI)反流症状。尽管 GERD 引起的慢性咳嗽非常普遍,但目前尚无有效的治疗方法,特别是对于没有 GI 症状的 GERD 相关咳嗽。由于草药 Ojeok-san 和 Saengmaek-san 可以有效治疗 GERD 和咳嗽,我们旨在评估这些成分组合缓解 GERD 引起的慢性咳嗽的疗效和安全性。

方法/设计:这是一项随机、双盲、安慰剂对照、单中心试验的研究方案。经过 1 周的导入期后,共有 30 名 GERD 引起的慢性咳嗽患者将被随机分配到干预组(n=15)或安慰剂组(n=15)。参与者将每天服用 5.76 克 Ojeok-san 加 Saengmaek-san 或安慰剂,每日 3 次,持续 6 周。主要结局指标,即咳嗽的频率和严重程度,将通过咳嗽日记记录。次要结局指标将包括咳嗽视觉模拟量表、莱斯特咳嗽问卷(韩文版)、胃肠道症状评分量表、赫尔空气反流(过敏)问卷、慢性咳嗽模式识别问卷、胃食管反流病模式识别问卷以及安全性测试。还将报告不良事件。

讨论

这将是第一项探索草药治疗 GERD 相关慢性咳嗽的临床试验,包括没有 GI 反流症状的患者。这项研究将提供关于 Ojeok-san 加 Saengmaek-san 治疗疗效和安全性的有用证据。此外,这项试验将为草药的联合使用提供科学依据。这项试验还将为 GERD 引起的慢性咳嗽的更大规模临床试验提供重要数据。

试验注册

该试验已在韩国临床研究信息服务(CRIS)(http://cris.nih.go.kr;注册号 KCT0003115)注册。于 2018 年 8 月 28 日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f084/6990619/8fba318a6601/13063_2019_4030_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验